Research Topics
| B L KasiskeSummaryAffiliation: University of Minnesota Country: USA Publications
| Collaborators
|
Detail Information
Publications
Clinical correlates to chronic renal allograft rejectionB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota, USA
Kidney Int Suppl 63:S71-4. 1997....
Epidemiology of cardiovascular disease after renal transplantationB L Kasiske
Department of of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, United States
Transplantation 72:S5-8. 2001....
Explained and unexplained ischemic heart disease risk after renal transplantationB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA
J Am Soc Nephrol 11:1735-43. 2000..The unexpected finding that dihydropyridine calcium channel antagonists were associated with an increased IHD risk merits further evaluation...
Payment for immunosuppression after organ transplantation. American Society of TransplantationB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minn 55415, USA
JAMA 283:2445-50. 2000..A number of potentially cost-effective approaches could be taken, but, in any case, something must be done to ensure that transplants do not fail because recipients cannot pay for immunosuppression...
Cigarette smoking in renal transplant recipientsB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA
J Am Soc Nephrol 11:753-9. 2000..The effects of smoking appear to dissipate 5 yr after quitting. These results indirectly suggest that greater efforts to encourage patients to quit smoking before transplantation may decrease morbidity and mortality...
Role of circulating lipid abnormalities in chronic renal allograft rejectionB L Kasiske
Department of Medicine, University of Minnesota College of Medicine, Hennepin County Medical Center, Minneapolis, USA
Kidney Int Suppl 71:S28-30. 1999..In any case, the hypothesis that circulating lipid abnormalities contribute to chronic renal allograft rejection deserves further testing in well-designed, clinical trials...
Successful renal transplantation in American IndiansB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA
Transplantation 66:209-14. 1998..The incidence of end-stage renal disease is rapidly growing among American Indians, but there have been no detailed reports of outcomes after renal transplantation in this population...
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of TransplantationB L Kasiske
Division of Nephrology, Hennepin County Medical Center, University of Minnesota, Minneapolis 55415, USA
J Am Soc Nephrol 11:S1-86. 2000..It is hoped that these guidelines will provide a framework for additional discussion and research that will improve the care of renal transplant recipients...
Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) StudyA K Israni
Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, USA
Am J Transplant 10:338-53. 2010..Thus, transplant-related risk factors, particularly those linked to graft function, explain much of the variation in CHD after kidney transplantation...
Earlier is not necessarily better in preemptive kidney transplantationS K Akkina
Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA
Am J Transplant 8:2071-6. 2008..89-2.05, p = 0.1588) for eGFR >or=15. Thus, early preemptive transplantation with higher eGFR does not necessarily improve graft survival after kidney transplantation, compared to preemptive transplantation with lower pretransplant eGFR...
OPTN/SRTR 2011 Annual Data Report: lungM Valapour
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:149-77. 2013..Posttransplant complications for pediatric lung transplant recipients, similar to complications for adult recipients, include hypertension, renal dysfunction, diabetes, bronchiolitis obliterans syndrome, and malignancy...
Similar outcomes with different rates of delayed graft function may reflect center practice, not center performanceS K Akkina
Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA
Am J Transplant 9:1460-6. 2009..3741) to that of recipients with SGF at UMMC. We conclude that dialysis per se is likely not a cause of worse graft outcomes. A better definition is needed to measure early graft dysfunction and its effects across transplant programs...
OPTN/SRTR 2011 Annual Data Report: pancreasR Kandaswamy
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:47-72. 2013..Rates of posttransplant re-hospitalization are high, most occurring in the first 6 months. Rejection rates are highest for PTA recipients, who also experience higher incidence of posttransplant lymphoproliferative disorder...
Comparing methods for monitoring serum creatinine to predict late renal allograft failureB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Am J Kidney Dis 38:1065-73. 2001..If confirmed in other populations, eg, patients treated with calcineurin inhibitors, this simple marker of chronic allograft dysfunction may prove to be a practical tool for defining patients at high risk for late graft failure...
OPTN/SRTR 2011 Annual Data Report: heartM Colvin-Adams
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:119-48. 2013..Short- and long-term graft survival has continued to improve. The effect on wait-list outcomes of a new pediatric heart allocation policy implemented in 2009 to reduce pediatric deaths on the waiting list cannot yet be determined...
OPTN/SRTR 2011 Annual Data Report: intestineJ M Smith
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:103-18. 2013..Hospitalization is common, occurring in 84.8% of recipients by 6 months posttransplant and in almost all by 4 years...
Troponin I levels and postoperative myocardial infarction following renal transplantationG R Shroff
Division of Cardiology, Hennepin County Medical Center, Minneapolis, MN 55155, USA
Am J Nephrol 35:175-80. 2012..The relationship of routine postoperative troponin I (TnI) monitoring in kidney transplant recipients and in-hospital myocardial infarction (MI) is not known...
The effects of lipid-lowering agents on acute renal allograft rejectionB L Kasiske
Department of Medicine, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN 55415, USA
Transplantation 72:223-7. 2001..The results of this study suggest that starting lipid-lowering therapy immediately after renal transplantation is both safe and effective in lowering total and low density lipoprotein cholesterol...
Dyslipidemia and its management after renal transplantationM A Andany
Department of Medicine Hennepin County Medical Center, Minneapolis, MN 55415, USA
J Nephrol 14:S81-8. 2001..In any case, hypercholesterolemia, and especially increases in low density lipoprotein cholesterol, should be treated using guidelines established for patients in the general population...
OPTN/SRTR 2011 Annual Data Report: liverW R Kim
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:73-102. 2013..Incidence of acute rejections increases with time after transplant. Posttransplant lymphoproliferative disorder remains an important concern in pediatric recipients...
Effect of comorbidity adjustment on CMS criteria for kidney transplant center performanceE D Weinhandl
United States Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 9:506-16. 2009..Lack of comorbidity adjustment may disadvantage centers willing to accept higher risk patients. Risk of jeopardizing Medicare funding may give centers incentive to deny transplantation to higher risk patients...
OPTN/SRTR 2011 Annual Data Report: kidneyA J Matas
Scientifc Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:11-46. 2013..Graft survival and short-term renal function continue to improve for pediatric recipients. Postransplant lymphoproliferative disorder is an important concern, occurring in about one-third of pediatric recipients...
Report of a consensus conference on transplant program quality and surveillanceB L Kasiske
Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota, USA
Am J Transplant 12:1988-96. 2012..Overall, there was broad consensus that substantial improvement in reporting outcomes of transplant programs in the United States could and should be made in a cost-effective manner...
A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal functionB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Am J Kidney Dis 31:954-61. 1998..Thus, although dietary protein restriction retards the rate of renal function decline, the relatively weak magnitude of this effect suggests that better therapies are needed to slow the rate of renal disease progression...
Subgroup analyses in randomized controlled trials: the need for risk stratification in kidney transplantationM Wagner
Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA, USA
Am J Transplant 9:2217-22. 2009..This approach may allow better individualized treatment choices for kidney transplant recipients...
Racial disparity trends for graft failure in the US pediatric kidney transplant population, 1980-2004B M Chavers
University of Minnesota, Minneapolis, MN, USA
Am J Transplant 9:543-9. 2009..Graft survival has improved slightly more for African American than white pediatric patients over the past 25 years. However, graft survival for African American pediatric patients remains poor compared with white patients...
A meta-analysis of immunosuppression withdrawal trials in renal transplantationB L Kasiske
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415
J Am Soc Nephrol 11:1910-7. 2000..63; range, 0.08 to 1.16, P = 0.190). Thus, unlike prednisone withdrawal, CsA withdrawal in select patients seems to impart little risk of long-term graft failure...
Cytomegalovirus disease is not a major risk factor for ischemic heart disease after renal transplantationD Hernandez
Department of Medicine, Hennepin County Medical Center, 701 Park Avenue South, Minneapolis, MN 55415, USA
Transplantation 72:1395-9. 2001..Both cytomegalovirus and ischemic heart disease are common after renal transplantation, suggesting a possible causal association in this population...
Optimizing the program-specific reporting of pancreas transplant outcomesB L Kasiske
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:337-47. 2013..Model calibration (Hosmer-Lemeshow method) was also acceptable. We conclude that pooling the results of SPK, PAK and PTA can produce potentially useful models for reporting program-specific pancreas transplant outcomes...
OPTN/SRTR 2011 Annual Data Report: deceased organ donationA K Israni
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:179-98. 2013....
OPTN/SRTR 2011 Annual Data Report: international dataB L Kasiske
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 13:199-225. 2013....
Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipientsB L Kasiske
Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, USA
Am J Transplant 8:1384-92. 2008..However, in the absence of the necessary clinical trials, dyslipidemia should be managed, as it would be in nontransplant patients at high risk for cardiovascular disease...
Lung and heart allocation in the United StatesM Colvin-Adams
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Transplant 12:3213-34. 2012..Here we examine the development of US lung and heart allocation policy, evaluate the application of the current policy on clinical practice and explore future directions for lung and heart allocation...
The geography of kidney transplantation in the United StatesB L Kasiske
Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, USA
Am J Transplant 8:647-57. 2008..The substantial variability in geographical access to kidney transplantation could have important implications for long-term care...
Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatinZ A Massy
Division of Nephrology, Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota, USA
Biochem Biophys Res Commun 267:536-40. 2000..Moreover, this inflammatory response can be prevented by lovastatin, providing a potential direct anti-inflammatory mechanism by which HMG-CoA reductase inhibitors may attenuate lipid-induced glomerular injury...
Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failureT Nemoto
Division of Nephrology, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota, USA
Kidney Int 60:2205-14. 2001..CONCLUSIONS: Small molecule selectin ligand inhibition provides a novel and effective approach to attenuate ischemic acute renal failure. Timing of treatment is crucial to success...
